Tudor Investment Corp
TLIS

Tudor Investment Corp’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History

Tudor Investment Corp’s Portfolio TLIS Stock Details TLIS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-667
Closed -$4.8K – 2988
2023
Q2 		$4.8K Hold
667
– – ﹤0.01% 2360
2023
Q1 		$5K Hold
667
– – ﹤0.01% 2329
2022
Q4 		$4K Hold
667
– – ﹤0.01% 2291
2022
Q3 		$7K Hold
667
– – ﹤0.01% 2236
2022
Q2 		$8K Hold
667
– – ﹤0.01% 2033
2022
Q1 		$14K Hold
667
– – ﹤0.01% 1907
2021
Q4 		$40K Buy
+667
New +$49.9K ﹤0.01% 2279
2021
Q2 		– Sell
-667
Closed -$129K – 2020
2021
Q1 		$129K Buy
+667
New +$166K ﹤0.01% 1477

Other funds holding TLIS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Tudor Investment Corp's TLIS Position: Q3 2023 in Review

Tudor Investment Corp sold out of Talis Biomedical Corporation Common Stock (TLIS) in Q3 2023, closing a stake of 667 shares — an estimated $4.8K sold.

Tudor Investment Corp first reported a position in TLIS in Q1 2021 and held it in 8 quarters. The position peaked at $129K in Q1 2021. 19 funds tracked by Wall St. Rank hold TLIS as of Q3 2023.

  • Tudor Investment Corp reported no remaining Talis Biomedical Corporation Common Stock position as of Q3 2023 after selling out during the quarter.
  • Tudor Investment Corp sold 667 Talis Biomedical Corporation Common Stock shares in Q3 2023, an estimated $4.8K.
  • Tudor Investment Corp first reported a position in Talis Biomedical Corporation Common Stock in Q1 2021 and held it in 8 quarters.
  • Tudor Investment Corp's Talis Biomedical Corporation Common Stock position peaked at $129K in Q1 2021.
  • 19 funds tracked by Wall St. Rank held Talis Biomedical Corporation Common Stock as of Q3 2023.

Based on Tudor Investment Corp's 13F filing for Q3 2023, filed 15 Nov 2023.